In another study, they used M1 macrophages exosomes transfected with NF-κB p50 siRNA and miR-511-3p to foster M2-like TAM reprogramming into a M1 phenotype, inhibiting tumor growth and stimulating anti-tumor immune response (96). The gene discussed is NFKB1; the disease is neoplasm.